The Lancet: November 22, 2012

David Cunningham from the Royal Marsden Hospital in London assesses the potential of regorafenib in the treatment of colorectal cancer and gastrointestinal stromal tumours.
Source: Listen to The Lancet - Category: General Medicine Authors: Source Type: podcasts